Alnylam Pharmaceuticals (ALNY) says the Court has ruled in its favor and denied Tekmira...

|About: Alnylam Pharmaceuticals, Inc. (ALNY)|By:, SA News Editor

Alnylam Pharmaceuticals (ALNY) says the Court has ruled in its favor and denied Tekmira Pharmaceuticals' motion to disqualify ALNY's counsel in an infringement suit ALNY filed in January. The suit is based upon allegations that Tekmira improperly provided lipid nanoparticle-formulated small interfering RNA molecules to pharmaceutical collaborators. In addition, ALNY says it's expanded the infringement action with a suit in Canada.